Natraj Proteins Statistics
Total Valuation
Natraj Proteins has a market cap or net worth of INR 117.47 million. The enterprise value is 319.26 million.
| Market Cap | 117.47M |
| Enterprise Value | 319.26M |
Important Dates
The next estimated earnings date is Monday, February 9, 2026.
| Earnings Date | Feb 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Natraj Proteins has 3.75 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 3.75M |
| Shares Outstanding | 3.75M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | 61.08% |
| Owned by Institutions (%) | 1.90% |
| Float | 1.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.11 |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 38.07, with an EV/FCF ratio of -5.42.
| EV / Earnings | -20.33 |
| EV / Sales | 0.29 |
| EV / EBITDA | 38.07 |
| EV / EBIT | 63.62 |
| EV / FCF | -5.42 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.81.
| Current Ratio | 1.54 |
| Quick Ratio | 0.48 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 28.22 |
| Debt / FCF | -4.02 |
| Interest Coverage | 0.24 |
Financial Efficiency
Return on equity (ROE) is -5.21% and return on invested capital (ROIC) is 0.97%.
| Return on Equity (ROE) | -5.21% |
| Return on Assets (ROA) | 0.57% |
| Return on Invested Capital (ROIC) | 0.97% |
| Return on Capital Employed (ROCE) | 1.63% |
| Weighted Average Cost of Capital (WACC) | 6.62% |
| Revenue Per Employee | 27.49M |
| Profits Per Employee | -392,600 |
| Employee Count | 40 |
| Asset Turnover | 2.01 |
| Inventory Turnover | 3.99 |
Taxes
In the past 12 months, Natraj Proteins has paid 2.71 million in taxes.
| Income Tax | 2.71M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.89% in the last 52 weeks. The beta is 0.26, so Natraj Proteins's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -28.89% |
| 50-Day Moving Average | 34.54 |
| 200-Day Moving Average | 39.00 |
| Relative Strength Index (RSI) | 45.48 |
| Average Volume (20 Days) | 2,215 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Natraj Proteins had revenue of INR 1.10 billion and -15.70 million in losses. Loss per share was -4.19.
| Revenue | 1.10B |
| Gross Profit | 73.70M |
| Operating Income | 5.02M |
| Pretax Income | -13.00M |
| Net Income | -15.70M |
| EBITDA | 8.39M |
| EBIT | 5.02M |
| Loss Per Share | -4.19 |
Balance Sheet
The company has 34.89 million in cash and 236.68 million in debt, with a net cash position of -201.79 million or -53.85 per share.
| Cash & Cash Equivalents | 34.89M |
| Total Debt | 236.68M |
| Net Cash | -201.79M |
| Net Cash Per Share | -53.85 |
| Equity (Book Value) | 293.23M |
| Book Value Per Share | 78.38 |
| Working Capital | 142.29M |
Cash Flow
In the last 12 months, operating cash flow was -56.16 million and capital expenditures -2.74 million, giving a free cash flow of -58.90 million.
| Operating Cash Flow | -56.16M |
| Capital Expenditures | -2.74M |
| Free Cash Flow | -58.90M |
| FCF Per Share | -15.72 |
Margins
Gross margin is 6.70%, with operating and profit margins of 0.46% and -1.43%.
| Gross Margin | 6.70% |
| Operating Margin | 0.46% |
| Pretax Margin | -1.18% |
| Profit Margin | -1.43% |
| EBITDA Margin | 0.76% |
| EBIT Margin | 0.46% |
| FCF Margin | n/a |
Dividends & Yields
Natraj Proteins does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | -13.37% |
| FCF Yield | -50.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |